Abstract
Elderly asthma (EA) is regarded as a distinct phenotype of asthma and is associated with age-related changes in airway structure and alterations in lung function and immune responses. EA is difficult to diagnose because of aging and co-morbidities, and overlaps with fixed airway obstructive disease. Novel modalities to differentiate between EA and chronic obstructive pulmonary disease (COPD) are necessary. A multifaceted approach, including clinical history, smoking habits, atopy, and measurement of lung function, is mandatory to differentiate asthma from COPD. There are a variety of co-morbidities with EA, of which COPD, upper airway diseases, depression, obesity, and hypertension are the most common, and these co-morbidities can affect the control status of EA. However, leukotriene receptor antagonists (LTRAs) can facilitate the management of EA, and thus addition of an LTRA to inhaled corticosteroid (ICS) monotherapy or ICS plus long-acting β2-agonist therapy improves symptoms in EA patients. LTRA treatment is safe and beneficial in patients who are unable to use inhalation devices properly or who have co-morbid diseases. Therefore, clinical studies targeting a specific population of EA patients are warranted to help achieve a better therapeutic strategy in EA patients.
Similar content being viewed by others
References
Yáñez A, Cho S-H, Soriano JB, Rosenwasser LJ, Rodrigo GJ, Rabe KF, et al. Asthma in the elderly: what we know and what we have yet to know. World Allergy Organ J. 2014;7:8.
Song WJ, Jee YK. More effective strategies are needed for elderly asthmatics in real-world practice. Allergy Asthma Immunol Res. 2015;7:419–20.
Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269–76.
Tsai CL, Lee WY, Hanania NA, Camargo CA Jr. Age-related differences in clinical outcomes for acute asthma in the United States, 2006–2008. J Allergy Clin Immunol. 2012;129(1252–8):e1.
Bellia V, Pedone C, Catalano F, Zito A, Davì E, Palange S, et al. Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest. 2007;132:1175–82.
Park HW, Kim TW, Song WJ, Kim SH, Park HK, Kim SH, et al. Prediction of asthma exacerbations in elderly adults: results of a 1-year prospective study. J Am Geriatr Soc. 2013;61:1631–2.
Ban GY, Ye YM, Lee Y, Kim JE, Nam YH, Lee SK, et al. Predictors of asthma control by stepwise treatment in elderly asthmatic patients. J Korean Med Sci. 2015;30:1042–7.
Hwang EK, Jin HJ, Nam YH, Shin YS, Ye YM, Nahm DH, et al. The predictors of poorly controlled asthma in elderly. Allergy Asthma Immunol Res. 2012;4:270–6.
Hanania NA, King MJ, Braman SS, Saltoun C, Wise RA, Enright P, et al. Asthma in the elderly: current understanding and future research needs—a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol. 2011;128:S4–24.
Battaglia S, Basile M, Spatafora M, Scichilone N. Are asthmatics enrolled in randomized trials representative of real-life outpatients. Respiration. 2015;89:383–9.
Ban GY, Trinh TH, Ye YM, Park HS. Predictors of asthma control in elderly patients. Curr Opin Allergy Clin Immunol. 2016;16:237–43.
Abramson MJ, Perret JL, Dharmage SC, McDonald VM, McDonald CF. Distinguishing adult-onset asthma from COPD: a review and a new approach. Int J Chron Obstruct Pulmon Dis. 2014;9:945.
Ross JA, Yang Y, Song PX, Clark NM, Baptist AP. Quality of life, health care utilization, and control in older adults with asthma. J Allergy Clin Immunol Pract. 2013;1:157–62.
Lee SM, Chang YS, Kim CW, Kim TB, Kim SH, Kwon YE, et al. Skills in handling turbuhaler, diskus, and pressurized metered-dose inhaler in Korean asthmatic patients. Allergy Asthma Immunol Res. 2011;3:46–52.
Kanaoka Y, Boyce JA. Cysteinyl leukotrienes and their receptors; emerging concepts. Allergy Asthma Immunol Res. 2014;6:288–95.
Chauhan BF, Ducharme FM. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev. 2012;(5):CD002314.
Boulet L-P. Asthma in the elderly patient. Asthma Res Pract. 2016;2:3. doi:10.1186/s40733-015-0015-1.
Battaglia S, Benfante A, Spatafora M, Scichilone N. Asthma in the elderly: a different disease? Breathe. 2016;12:18.
Song WJ, Cho SH. Challenges in the management of asthma in the elderly. Allergy Asthma Immunol Res. 2015;7:431–9.
Larj M, Georas S, Smith SM, Khurana S, Bhaskar J. Differences between early-and late-onset asthma; data from an asthma registry. B14. Asthma phenotyping: understanding of pathogenesis and rationale for new therapies. Am Thoracic Soc; 2013. p. A2325-A.
de Nijs SB, Venekamp LN, Bel EH. Adult-onset asthma: is it really different? Eur Respir Rev. 2013;22:44–52.
Rönmark E, Lindberg A, Watson L, Lundbäck B. Outcome and severity of adult onset asthma—report from the obstructive lung disease in northern Sweden studies (OLIN). Respir Med. 2007;101:2370–7.
Park J, Kim TB, Joo H, Lee JS, Lee SD, Oh YM. Diseases concomitant with asthma in middle-aged and elderly subjects in Korea: a population-based study. Allergy Asthma Immunol Res. 2013;5:16–25.
Lindner K, Panaszek B, Machaj Z. Asthma in the elderly. Pol Arch Med Wewn. 2007;117:350–4.
Zureik M, Orehek J. Diagnosis and severity of asthma in the elderly: results of a large survey in 1485 asthmatics recruited by lung specialists. Respiration. 2002;69:223–8.
Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet. 2010;376:803–13.
Mathur SK, Nyenhuis SM. Changes in immune function in asthma in the elderly. Aging Health. 2009;5:551–9.
Benfante A, Scichilone N. The geriatric asthma: pitfalls and challenges. Asthma Res Pract. 2016;2:1–4.
Ding DJ, Martin J, Macklem P. Effects of lung volume on maximal methacholine-induced bronchoconstriction in normal humans. J Appl Physiol. 1987;62:1324–30.
Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1:253.
Murray MA, Chotirmall SH. The impact of immunosenescence on pulmonary disease. Mediat Inflamm. 2015;2015:692546.
Agarwal S, Busse PJ. Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol. 2010;104:183–90 (quiz 90-2, 210).
Tzortzaki EG, Proklou A, Siafakas NM. Asthma in the elderly: can we distinguish it from COPD? J Allergy. 2011;2011:843543. doi:10.1155/2011/843543.
Ducharme ME, Prince P, Hassan N, Nair P, Boulet LP. Expiratory flows and airway inflammation in elderly asthmatic patients. Respir Med. 2011;105:1284–9.
Porsbjerg CM, Gibson PG, Pretto JJ, Salome CM, Brown NJ, Berend N, et al. Relationship between airway pathophysiology and airway inflammation in older asthmatics. Respirology. 2013;18:1128–34.
Meyer KC, Rosenthal NS, Soergel P, Peterson K. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev. 1998;104:169–81.
Chotirmall SH, Burke CM. Aging and the microbiome: implications for asthma in the elderly? Expert Rev Respir Med. 2015;9:125–8.
Gollwitzer ES, Saglani S, Trompette A, Yadava K, Sherburn R, McCoy KD, et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat Med. 2014;20:642–7.
Global Initiative for Asthma. Global strategy for asthma management and prevention (updated 2015). http://www.ginasthma.org. Accessed 15 Mar 2016.
Demoly P, Paggiaro P, Plaza V, Bolge S, Kannan H, Sohier B, et al. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev. 2009;18:105–12.
Bozek A, Filipowski M, Fischer A, Jarzab J. Characteristics of atopic bronchial asthma in seniors over 80 years of age. Biomed Res Int. 2013;2013:689782.
Chotirmall SH, Watts M, Branagan P, Donegan CF, Moore A, McElvaney NG. Diagnosis and management of asthma in older adults. J Am Geriatr Soc. 2009;57:901–9.
Bellia V, Pistelli R, Catalano F, Antonelli-Incalzi R, Grassi V, Melillo G, et al. Quality control of spirometry in the elderly: the SA.RA study. Am J Respir Crit Care Med. 2000;161:1094–100.
Haynes JM. Pulmonary function test quality in the elderly: a comparison with younger adults. Respir Care. 2014;59:16–21.
Allen SC, Baxter M. A comparison of four tests of cognition as predictors of inability to perform spirometry in old age. Age Ageing. 2009;38(5):537–41.
Enright PL, Kronmal RA, Higgins M, Schenker M, Haponik EF. Spirometry reference values for women and men 65 to 85 years of age. Am Rev Respir Dis. 1993;147:e133.
Sorino C, Sherrill D, Guerra S, Enright P, Pedone C, Augugliaro G, et al. Prognostic value of FEV1/FEV6 in elderly people. Clin Physiol Funct Imaging. 2011;31:101–7.
Cuttitta G, Cibella F, Bellia V, Grassi V, Cossi S, Bucchieri S, et al. Changes in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma: bronchial hyperresponsiveness and aging. Chest. 2001;119:1685–90.
Gergen PJ, Arbes SJ Jr, Calatroni A, Mitchell HE, Zeldin DC. Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol. 2009;124:447–53.
Litonjua AA, Sparrow D, Weiss ST, O’Connor GT, Long AA, Ohman JL Jr. Sensitization to cat allergen is associated with asthma in older men and predicts new-onset airway hyperresponsiveness: the Normative Aging Study. Am J Respir Crit Care Med. 1997;156:23–7.
King MJ, Bukantz SC, Phillips S, Mohapatra SS, Tamulis T, Lockey RF. Serum total IgE and specific IgE to Dermatophagoides pteronyssinus, but not eosinophil cationic protein, are more likely to be elevated in elderly asthmatic patients. Allergy Asthma Proc. 2004;25(5):321–5.
Bellia V, Battaglia S, Catalano F, Scichilone N, Incalzi RA, Imperiale C, et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest. 2003;123:1066–72.
Sin B, Akkoca O, Saryal S, Oner F, Misirligil Z. Differences between asthma and COPD in the elderly. J Investig Allergol Clin Immunol. 2006;16:44–50.
Tamada T, Sugiura H, Takahashi T, Matsunaga K, Kimura K, Katsumata U, et al. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations. Int J Chron Obstruct Pulmon Dis. 2015;10:2169–76.
Columbo M, Wong B, Panettieri RA, Rohr AS. Asthma in the elderly: the role of exhaled nitric oxide measurements. Respir Med. 2013;107:785–7.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2015). http://www.goldcopd.org. Accessed 15 Mar 2016.
Di Lorenzo G, Mansueto P, Ditta V, Esposito-Pellitteri M, Bianco CL, Leto-Barone MS, et al. Similarity and differences in elderly patients with fixed airflow obstruction by asthma and by chronic obstructive pulmonary disease. Respir Med. 2008;102:232–8.
Gelb AF, Yamamoto A, Mauad T, Kollin J, Schein MJ, Nadel JA. Unsuspected mild emphysema in nonsmoking patients with chronic asthma with persistent airway obstruction. J Allergy Clin Immunol. 2014;133:263–5.e1–3.
de Marco R, Cappa V, Accordini S, Rava M, Antonicelli L, Bortolami O, et al. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J. 2012;39:883–92.
Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11:54–61.
D’silva L, Hassan N, Wang H-Y, Kjarsgaard M, Efthimiadis A, Hargreave FE, et al. Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Can Respir J. 2011;18:144–8.
Wardzynska A, Kubsik B, Kowalski ML. Comorbidities in elderly patients with asthma: association with control of the disease and concomitant treatment. Geriatr Gerontol Int. 2015;15:902–9.
Haselkorn T, Chen H, Miller DP, Fish JE, Peters SP, Weiss ST, et al. Asthma control and activity limitations: insights from the Real-world Evaluation of Asthma Control and Treatment (REACT) study. Ann Allergy Asthma Immunol. 2010;104:471–7.
Adams RJ, Wilson DH, Taylor AW, Daly A, Tursan d’Espaignet E, Dal Grande E, et al. Coexistent chronic conditions and asthma quality of life: a population-based study. Chest. 2006;129:285–91.
Agusta F, Battaglia S, Benfante A, Spatafora M, Scichilone N. Challenges in the pharmacological treatment of geriatric asthma. Expert Rev Clin Pharmacol. 2016;9(7):917–26.
Patel MR, Janevic MR, Heeringa SG, Baptist AP, Clark NM. An examination of adverse asthma outcomes in U.S. adults with multiple morbidities. Ann Am Thorac Soc. 2013;10:426–31.
Zeki AA, Schivo M, Chan A, Albertson TE, Louie S. The asthma-COPD overlap syndrome: a common clinical problem in the elderly. J Allergy (Cairo). 2011;2011:861926.
Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M, et al. Global multimorbidity patterns: a cross-sectional, population-based, multi-country study. J Gerontol A Biol Sci Med Sci. 2016;71:205–14.
Milanese M, Di Marco F, Corsico AG, Rolla G, Sposato B, Chieco-Bianchi F, ELSA Study Group, et al. Asthma control in elderly asthmatics. An Italian observational study. Respir Med. 2014;108:1091–9.
Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpeläinen M, Kinnula VL, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48:279–85.
Gerhardsson de Verdier M, Andersson M, Kern DM, Zhou S, Tunceli O. Asthma and chronic obstructive pulmonary disease overlap syndrome: doubled costs compared with patients with asthma alone. Value Health. 2015;18:759–66.
Menezes AM, Montes de Oca M, Perez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145:297–304.
Lee JH, Chung JW, Kong KA, Lee S, Ryu YJ, Chang JH. Characteristics and self-rated health of overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2014;9:795–804.
van den Berge M, Aalbers R. The asthma-COPD overlap syndrome: how is it defined and what are its clinical implications? J Asthma Allergy. 2016;9:27–35.
Alvarado-Gonzalez A, Arce I. Tiotropium bromide in chronic obstructive pulmonary disease and bronchial asthma. J Clin Med Res. 2015;7:831–9.
Barrecheguren M, Monteagudo M, Ferrer J, Borrell E, Llor C, Esquinas C, et al. Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study. Respir Med. 2016;111:47–53.
Postma DS, Rabe KF. The asthma-COPD overlap syndrome. N Engl J Med. 2015;373:1241–9.
Wuthrich B, Schmid-Grendelmeier P, Schindler C, Imboden M, Bircher A, Zemp E, et al. Prevalence of atopy and respiratory allergic diseases in the elderly SAPALDIA population. Int Arch Allergy Immunol. 2013;162:143–8.
Jarvis D, Newson R, Lotvall J, Hastan D, Tomassen P, Keil T, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA(2)LEN survey in Europe. Allergy. 2012;67:91–8.
Ek A, Middelveld RJ, Bertilsson H, Bjerg A, Ekerljung L, Malinovschi A, et al. Chronic rhinosinusitis in asthma is a negative predictor of quality of life: results from the Swedish GA(2)LEN survey. Allergy. 2013;68:1314–21.
Song WJ, Sintobin I, Sohn KH, Kang MG, Park HK, Jo EJ, et al. Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderly. Clin Exp Allergy. 2016;46(3):411–21.
Lombardi C, Raffetti E, Caminati M, Liccardi G, Passalacqua G, Reccardini F, et al. Phenotyping asthma in the elderly: allergic sensitization profile and upper airways comorbidity in patients older than 65 years. Ann Allergy Asthma Immunol. 2016;116(3):206–11.
Pite H, Pereira AM, Morais-Almeida M, Nunes C, Bousquet J, Fonseca JA. Prevalence of asthma and its association with rhinitis in the elderly. Respir Med. 2014;108:1117–26.
Kvamme J-M, Wilsgaard T, Florholmen J, Jacobsen BK. Body mass index and disease burden in elderly men and women: the Tromsø Study. Eur J Epidemiol. 2010;25:183–93.
Leone N, Courbon D, Berr C, Barberger-Gateau P, Tzourio C, Alperovitch A, et al. Abdominal obesity and late-onset asthma: cross-sectional and longitudinal results: the 3C study. Obesity (Silver Spring). 2012;20:628–35.
Song WJ, Kim SH, Lim S, Park YJ, Kim MH, Lee SM, et al. Association between obesity and asthma in the elderly population: potential roles of abdominal subcutaneous adiposity and sarcopenia. Ann Allergy Asthma Immunol. 2012;109:243–8.
Peters MC, Fahy JV. Metabolic consequences of obesity as an “outside in” mechanism of disease severity in asthma. Eur Respir J. 2016;48:291–3.
Celebi Sozener Z, Aydin O, Mungan D, Misirligil Z. Obesity-asthma phenotype: effect of weight gain on asthma control in adults. Allergy Asthma Proc. 2016;37:311–7.
Kim SH, Sutherland ER, Gelfand EW. Is there a link between obesity and asthma? Allergy Asthma Immunol Res. 2014;6:189–95.
Sutherland ER. Linking obesity and asthma. Ann N Y Acad Sci. 2014;1311:31–41.
Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J. 2009;33:897–906.
Park HW, Song WJ, Kim SH, Park HK, Kwon YE, Kwon HS, et al. Classification and implementation of asthma phenotypes in elderly patients. Ann Allergy Asthma Immunol. 2015;114:18–22.
Choi GS, Shin YS, Kim JH, Choi SY, Lee SK, Nam YH, et al. Prevalence and risk factors for depression in Korean adult patients with asthma: is there a difference between elderly and non-elderly patients? J Korean Med Sci. 2014;29:1626–31.
Gao YH, Zhao HS, Zhang FR, Gao Y, Shen P, Chen RC, et al. The relationship between depression and asthma: a meta-analysis of prospective studies. PLoS One. 2015;10:e0132424.
Hutter N, Knecht A, Baumeister H. Health care costs in persons with asthma and comorbid mental disorders: a systematic review. Gen Hosp Psychiatry. 2011;33:443–53.
Krauskopf KA, Sofianou A, Goel MS, Wolf MS, Wilson EA, Martynenko ME, et al. Depressive symptoms, low adherence, and poor asthma outcomes in the elderly. J Asthma. 2013;50:260–6.
Han YY, Forno E, Marsland AL, Miller GE, Celedon JC. Depression, asthma, and bronchodilator response in a nationwide study of US Adults. J Allergy Clin Immunol Pract. 2016;4(68–73):e1.
Gerald JK, Moreno FA. Asthma and depression: it’s complicated. J Allergy Clin Immunol Pract. 2016;4:74–5.
Christiansen SC, Schatz M, Yang SJ, Ngor E, Chen W, Zuraw BL. Hypertension and asthma: a comorbid relationship. J Allergy Clin Immunol Pract. 2016;4:76–81.
Christiansen CF, Christensen S, Mehnert F, Cummings SR, Chapurlat RD, Sorensen HT. Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study. Arch Intern Med. 2009;169:1677–83.
Dogra S, Ardern CI, Baker J. The relationship between age of asthma onset and cardiovascular disease in Canadians. J Asthma. 2007;44:849–54.
Lee HM, Truong ST, Wong ND. Association of adult-onset asthma with specific cardiovascular conditions. Respir Med. 2012;106:948–53.
Ferguson S, Teodorescu MC, Gangnon RE, Peterson AG, Consens FB, Chervin RD, et al. Factors associated with systemic hypertension in asthma. Lung. 2014;192:675–83.
Vaquerizo M, Casan P, Castillo J, Perpina M, Sanchis J, Sobradillo V, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax. 2003;58:204–10.
Storms W, Michele T, Knorr B, Noonan G, Shapiro G, Zhang J, et al. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥6 years. Clin Exp Allergy. 2001;31:77–87.
Williams B, Noonan G, Reiss T, Knorr B, Guerra J, White R, et al. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older. Clin Exp Allergy. 2001;31:845–54.
Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS, et al. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. J Allergy Clin Immunol. 2007;119:916–23.
Pearlman DS, White MV, Lieberman AK, Pepsin PJ, Kalberg C, Emmett A, et al. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma. Ann Allergy Asthma Immunol. 2002;88:227–35.
Bozek A, Warkocka-Szoltysek B, Filipowska-Gronska A, Jarzab J. Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients. J Asthma. 2012;49:530–4.
Korenblat PE, Kemp JP, Scherger JE, Minkwitz MC, Mezzanotte W. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT). Ann Allergy Asthma Immunol. 2000;84:217–25.
Horiguchi T, Tachikawa S, Kondo R, Miyazaki J, Shiga M, Hirose M, et al. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma. Arzneimittelforschung. 2006;57:87–91.
Ye YM, Kim SH, Hur GY, Kim JH, Park JW, Shim JJ, et al. Addition of montelukast to low-dose inhaled corticosteroid leads to fewer exacerbations in older patients than medium-dose inhaled corticosteroid monotherapy. Allergy Asthma Immunol Res. 2015;7:440–8.
Health Products Regulatory Authority. Summary of product characteristics. 2016. https://www.hpra.ie/img/uploaded/swedocuments/LicenseSPC_PA1390-030-003_19062015140038.pdf. Accessed 17 June 2016.
Federman AD, Wolf MS, Sofianou A, Martynenko M, O’Connor R, Halm EA, et al. Self-management behaviors in older adults with asthma: associations with health literacy. J Am Geriatr Soc. 2014;62:872–9.
Scichilone N, Battaglia S, Benfante A, Bellia V. Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients. Clin Interv Aging. 2013;8:1329–37.
Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167:418–24.
Gangemi S, Pescara L, D’Urbano E, Basile G, Nicita-Mauro V, Davì G, et al. Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. Exp Gerontol. 2005;40:612–4.
Ingelsson E, Yin L, Bäck M. Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease. J Allergy Clin Immunol. 2012;129(702–7):e2.
Barnes N, Thomas M, Price D, Tate H. The national montelukast survey. J Allergy Clin Immunol. 2005;115:47–54.
Weinreich UM, Thomsen LP, Brock C, Karbing DS, Rees SE. Diffusion capacity of the lung for carbon monoxide—a potential marker of impaired gas exchange or of systemic deconditioning in chronic obstructive lung disease? Chron Respir Dis. 2015;12:357–64.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (HI16C0992)
Conflict of interest
HKT Trinh, GY Ban, JH Lee, HS Park declare no conflicts of interest in relation to the contents of this review.
Rights and permissions
About this article
Cite this article
Trinh, H.K.T., Ban, GY., Lee, JH. et al. Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients. Drugs Aging 33, 699–710 (2016). https://doi.org/10.1007/s40266-016-0401-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-016-0401-2